Claims for Patent: 7,696,162

✉ Email this page to a colleague

Summary for Patent: 7,696,162

Title:	Zinc-free and low-zinc insulin preparations having improved stability
Abstract:	The invention relates to a formulation comprising a polypeptide selected from at least one of insulin, an insulin metabolite, an insulin analog, and an insulin derivative; at least one surfactant; optionally at least one preservative; and optionally at least one of an isotonicizing agent, a buffer or an excipient, wherein the formulation is free from or low in zinc. The invention also relates to the production of such insulin preparations and their use as pharmaceutical formulations.
Inventor(s):	Peter Boderke
Assignee:	Sanofi Aventis Deutschland GmbH
Application Number:	US12/285,464

Details for Patent 7,696,162

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Sanofi-aventis U.s. Llc	APIDRA	insulin glulisine	Injection	021629	April 16, 2004	⤷ Get Started Free	2028-10-06
Sanofi-aventis U.s. Llc	APIDRA	insulin glulisine	Injection	021629	December 20, 2005	⤷ Get Started Free	2028-10-06
Sanofi-aventis U.s. Llc	APIDRA	insulin glulisine	Injection	021629	February 24, 2009	⤷ Get Started Free	2028-10-06
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 7,696,162

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
South Africa	200306637	⤷ Get Started Free
Yugoslavia	73503	⤷ Get Started Free
World Intellectual Property Organization (WIPO)	02076495	⤷ Get Started Free
United States of America	7452860	⤷ Get Started Free
United States of America	7205277	⤷ Get Started Free
United States of America	7205276	⤷ Get Started Free
United States of America	6960561	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.